Deerfield Management as of Dec. 31, 2015
Portfolio Holdings for Deerfield Management
Deerfield Management holds 108 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Horizon Pharma | 10.3 | $253M | 12M | 21.67 | |
NxStage Medical | 4.1 | $101M | 4.6M | 21.91 | |
Teva Pharmaceutical Industries (TEVA) | 3.6 | $90M | 1.4M | 65.64 | |
Dyax | 3.4 | $84M | 2.2M | 37.62 | |
Adeptus Health Inc-class A | 2.9 | $71M | 1.3M | 54.52 | |
GlaxoSmithKline | 2.7 | $68M | 1.7M | 40.35 | |
Aetna | 2.6 | $64M | 592k | 108.12 | |
DaVita (DVA) | 2.3 | $57M | 822k | 69.71 | |
Mylan Nv | 2.3 | $57M | 1.1M | 54.07 | |
Vanda Pharmaceuticals (VNDA) | 2.3 | $56M | 6.0M | 9.31 | |
Gilead Sciences (GILD) | 2.2 | $54M | 532k | 101.19 | |
Flamel Technologies | 2.0 | $50M | 4.1M | 12.21 | |
Healthways Inc note 1.500% 7/0 | 2.0 | $49M | 52M | 0.95 | |
Array Biopharma Inc note 3.000% 6/0 | 1.7 | $42M | 45M | 0.94 | |
Global Blood Therapeutics In | 1.5 | $38M | 1.2M | 32.33 | |
Heartware Intl Inc note 3.500%12/1 | 1.5 | $37M | 39M | 0.95 | |
Array BioPharma | 1.5 | $37M | 8.7M | 4.22 | |
Portola Pharmaceuticals | 1.4 | $35M | 684k | 51.45 | |
Endologix Inc note 2.250%12/1 | 1.4 | $35M | 41M | 0.85 | |
Sage Therapeutics (SAGE) | 1.4 | $35M | 599k | 58.30 | |
XenoPort | 1.4 | $35M | 6.3M | 5.49 | |
Aac Holdings | 1.4 | $34M | 1.8M | 19.06 | |
Infinity Pharmaceuticals (INFIQ) | 1.4 | $34M | 4.3M | 7.85 | |
Universal American | 1.4 | $34M | 4.8M | 7.00 | |
Walgreen Boots Alliance (WBA) | 1.3 | $33M | 387k | 85.16 | |
eHealth (EHTH) | 1.3 | $33M | 3.3M | 9.98 | |
Endologix, Inc. 3.25% 11/01/2020 | 1.3 | $32M | 30M | 1.08 | |
Healthways | 1.3 | $32M | 2.5M | 12.87 | |
Accuray Inc Del note 3.750% 8/0 | 1.2 | $31M | 31M | 1.01 | |
Charles River Laboratories (CRL) | 1.2 | $30M | 377k | 80.39 | |
Nivalis Therapeutics | 1.2 | $29M | 3.7M | 7.74 | |
McKesson Corporation (MCK) | 1.2 | $29M | 145k | 197.23 | |
Genomic Health | 1.1 | $29M | 809k | 35.20 | |
Pacira Pharmaceuticals (PCRX) | 1.1 | $29M | 371k | 76.79 | |
Five Prime Therapeutics | 1.1 | $28M | 680k | 41.50 | |
Kempharm | 1.1 | $28M | 1.4M | 19.86 | |
Pronai Therapeutics | 1.1 | $27M | 1.8M | 15.04 | |
Relypsa | 1.0 | $26M | 900k | 28.34 | |
Spectranetics Corp mtnf 2.625% 6/0 | 0.9 | $23M | 30M | 0.76 | |
Gw Pharmaceuticals Plc ads | 0.9 | $22M | 310k | 69.44 | |
Aerie Pharmaceuticals | 0.8 | $20M | 808k | 24.35 | |
Proteon Therapeutics | 0.8 | $20M | 1.3M | 15.51 | |
Cytomx Therapeutics (CTMX) | 0.8 | $20M | 946k | 20.87 | |
Rite Aid Corporation | 0.8 | $20M | 2.5M | 7.84 | |
Regenxbio Inc equity us cm (RGNX) | 0.8 | $19M | 1.2M | 16.60 | |
Pacific Biosciences of California (PACB) | 0.7 | $18M | 1.4M | 13.13 | |
Xencor (XNCR) | 0.7 | $18M | 1.3M | 14.62 | |
Achillion Pharmaceuticals | 0.7 | $18M | 1.7M | 10.79 | |
Fluidigm Corporation convertible cor | 0.7 | $18M | 28M | 0.64 | |
Axogen (AXGN) | 0.7 | $17M | 3.4M | 5.00 | |
Dbv Technologies S A | 0.7 | $17M | 462k | 36.31 | |
Akari Therapeutics | 0.7 | $17M | 1.2M | 14.50 | |
Centene Corporation (CNC) | 0.7 | $16M | 244k | 65.81 | |
Macrogenics (MGNX) | 0.7 | $16M | 518k | 30.97 | |
Cardiovascular Systems | 0.6 | $16M | 1.0M | 15.12 | |
Endochoice Hldgs | 0.6 | $15M | 1.8M | 8.35 | |
Alimera Sciences | 0.6 | $14M | 5.9M | 2.42 | |
Imprivata | 0.6 | $14M | 1.2M | 11.30 | |
Allscripts Healthcare So conv | 0.5 | $13M | 12M | 1.08 | |
Nanostring Technologies (NSTGQ) | 0.5 | $13M | 881k | 14.71 | |
Galapagos Nv- (GLPG) | 0.5 | $12M | 183k | 62.88 | |
Acceleron Pharma | 0.4 | $10M | 214k | 48.76 | |
Trupanion (TRUP) | 0.4 | $10M | 1.1M | 9.76 | |
Tonix Pharmaceuticls | 0.4 | $10M | 1.3M | 7.67 | |
Invuity | 0.4 | $9.5M | 1.1M | 8.82 | |
Essa Pharma | 0.3 | $8.5M | 1.9M | 4.57 | |
HeartWare International | 0.3 | $8.1M | 160k | 50.40 | |
Foamix Pharmaceuticals | 0.3 | $7.7M | 949k | 8.11 | |
Rigel Pharmaceuticals | 0.3 | $7.3M | 2.4M | 3.03 | |
Loxo Oncology | 0.3 | $7.1M | 251k | 28.45 | |
Alcobra | 0.3 | $6.7M | 1.1M | 6.28 | |
Neos Therapeutics | 0.3 | $6.6M | 458k | 14.32 | |
Versartis | 0.2 | $6.1M | 491k | 12.39 | |
pSivida | 0.2 | $5.9M | 1.2M | 4.82 | |
Oxford Immunotec Global | 0.2 | $6.0M | 520k | 11.50 | |
CAS Medical Systems | 0.2 | $5.7M | 3.2M | 1.77 | |
Zafgen | 0.2 | $5.3M | 844k | 6.29 | |
Myokardia | 0.2 | $5.5M | 375k | 14.66 | |
Egalet | 0.2 | $5.3M | 477k | 11.02 | |
Catabasis Pharmaceuticals | 0.2 | $5.1M | 644k | 7.93 | |
Jazz Investments I Ltd. conv | 0.2 | $5.2M | 5.0M | 1.04 | |
Voyager Therapeutics (VYGR) | 0.2 | $5.2M | 235k | 21.90 | |
Antares Pharma | 0.2 | $4.8M | 4.0M | 1.21 | |
Aldeyra Therapeutics (ALDX) | 0.2 | $4.7M | 691k | 6.78 | |
Genocea Biosciences | 0.2 | $4.4M | 837k | 5.27 | |
Scynexis | 0.2 | $4.3M | 696k | 6.21 | |
Steadymed | 0.2 | $4.4M | 1.3M | 3.26 | |
Tracon Pharmaceuticals | 0.2 | $4.5M | 485k | 9.24 | |
Alliqua | 0.2 | $4.0M | 1.9M | 2.14 | |
Genesis Healthcare Inc Cl A (GENN) | 0.1 | $3.3M | 964k | 3.47 | |
Immunomedics | 0.1 | $3.3M | 1.1M | 3.07 | |
Trinity Biotech | 0.1 | $2.9M | 246k | 11.76 | |
Veracyte (VCYT) | 0.1 | $2.8M | 392k | 7.20 | |
Cti Biopharma | 0.1 | $2.8M | 2.2M | 1.23 | |
Acura Pharmaceuticals (ACUR) | 0.1 | $2.6M | 1.0M | 2.50 | |
Trillium Therapeutics, Inc. Cmn | 0.1 | $2.2M | 172k | 12.61 | |
Anthem (ELV) | 0.1 | $2.0M | 15k | 139.46 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $2.0M | 120k | 17.16 | |
Alphatec Holdings | 0.1 | $1.5M | 5.0M | 0.30 | |
Bovie Medical Corporation | 0.1 | $1.4M | 688k | 2.10 | |
Caredx (CDNA) | 0.1 | $1.5M | 229k | 6.40 | |
Palatin Technologies | 0.1 | $1.3M | 2.0M | 0.66 | |
Streamline Health Solutions | 0.0 | $935k | 663k | 1.41 | |
Corsicanto Ltd conv bnd | 0.0 | $900k | 1.0M | 0.90 | |
Rennova Health | 0.0 | $755k | 559k | 1.35 | |
AmerisourceBergen (COR) | 0.0 | $311k | 3.0k | 103.67 | |
Pozen | 0.0 | $305k | 45k | 6.84 | |
Rennova Health Inc. Warrants *w | 0.0 | $284k | 645k | 0.44 |